|
ALG11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.65689994846963E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.03800000004351E-07 |
| Normal-vs-Stage2 |
1.432890E-04 |
| Normal-vs-Stage3 |
1.16673337657858E-12 |
| Normal-vs-Stage4 |
1.62070999999431E-05 |
| Stage1-vs-Stage2 |
9.688400E-01 |
| Stage1-vs-Stage3 |
4.457100E-03 |
| Stage1-vs-Stage4 |
8.189600E-01 |
| Stage2-vs-Stage3 |
8.159700E-02 |
| Stage2-vs-Stage4 |
8.260800E-01 |
| Stage3-vs-Stage4 |
7.270500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.42580000531234E-08 |
| Normal-vs-AfricanAmerican |
8.900500E-03 |
| Normal-vs-Asian |
1.54141999999524E-05 |
| Caucasian-vs-AfricanAmerican |
2.403400E-01 |
| Caucasian-vs-Asian |
7.865000E-01 |
| AfricanAmerican-vs-Asian |
3.323000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.09679999818979E-08 |
| Normal-vs-Female |
1.99790000099398E-08 |
| Male-vs-Female |
9.366600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.22819999953872E-07 |
| Normal-vs-Age(41-60Yrs) |
8.45309999775168E-08 |
| Normal-vs-Age(61-80Yrs) |
6.81299461291474E-11 |
| Normal-vs-Age(81-100Yrs) |
3.53980000000753E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.559400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.373550E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.348000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.480390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.009800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.740000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.763200E-01 |
| Classical-VS-Follicular |
5.160600E-01 |
| Classical-VS-Other |
9.605800E-01 |
| Classical-VS-Normal |
7.11970482569768E-11 |
| Tall-VS-Follicular |
1.768630E-01 |
| Tall-VS-Other |
6.183800E-01 |
| Tall-VS-Normal |
3.39419999995094E-07 |
| Follicular-VS-Other |
8.225000E-01 |
| Follicular-VS-Normal |
4.597100E-04 |
| Other-VS-Normal |
1.715990E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.24990018335325E-10 |
| Normal-vs-N1 |
5.64730000540692E-08 |
| N0-vs-N1 |
6.779600E-01 |
|
|
